Xponance, Inc. Sorrento Therapeutics, Inc. Transaction History

Xponance, Inc.

7 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q4 2022 Jan 23, 2023	BUY	$0.74 - $1.83 $3,785 - $9,360	5,115 Added 24.09%	26,348 $0
Q3 2022 Oct 24, 2022	BUY	$1.51 - $2.88 $1,426 - $2,721	945 Added 4.66%	21,233 $33,000
Q2 2022 Aug 02, 2022	BUY	$1.24 - $2.33 $7,549 - $14,185	6,088 Added 42.87%	20,288 $41,000
Q1 2022 Apr 20, 2022	BUY	$2.0 - $4.9 $234 - $573	117 Added 0.83%	14,200 $33,000
Q4 2021 Jan 31, 2022	BUY	$4.65 - $7.23 $4,719 - $7,338	1,015 Added 7.77%	14,083 $65,000
Q3 2021 Nov 05, 2021	SELL	$7.41 - $10.99 $13,760 - $20,408	-1,857 Reduced 12.44%	13,068 $100,000
Q2 2021 Aug 12, 2021	BUY	$6.35 - $10.0 $94,773 - $149,250	14,925 New	14,925 $145,000

5.47M

Ticker SRNE
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 449,952,000
Market Cap $148M
Description
Sorrento Therapeutics, Inc., a clinical stage and commercial biopharmaceutical company, develops therapies for cancer, autoimmune, inflammatory, viral, and neurodegenerative diseases. It operates through two segments, Sorrento Therapeutics and Scilex. The company provides cancer therapeutic by leveraging its proprietary G-MAB antibody library an...

Get notified when there are updates to the investment portfolio of Xponance, Inc., based on Form 13F filings with the SEC.

Stay updated on Xponance, Inc. with notifications on news.